Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ironwood Pharmaceuticals Inc (IRWD)  
$8.12 0.18 (2.17%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 173,744,000
Market Cap: 1.41(B)
Last Volume: 148,509 Avg Vol: 0
52 Week Range: $7.6 - $15.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 8.3
Insider 6 Months    : 8.3
Insider 3/6 Months : 16.7
Guru Rank Number :  607
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focusing on developing the treatment of GI diseases. LINZESS® (linaclotide), Co.'s commercial product, is a product in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is available to adult men and women suffering from IBS-C or CIC in the U.S. and Mexico and to adult men and women suffering from IBS-C in Japan and China. Co. has partnerships with pharmaceutical companies to support the development and commercialization of linaclotide.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 17,604 17,604 53,676 53,676
Total Buy Value $160,420 $160,420 $460,539 $460,539
Total People Bought 2 2 2 2
Total Buy Transactions 2 2 3 3
Total Shares Sold 280,916 294,129 403,559 1,047,483
Total Sell Value $4,281,159 $4,424,082 $5,556,813 $12,970,668
Total People Sold 5 6 6 9
Total Sell Transactions 5 7 14 48
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 914
  Page 7 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sarissa Capital Management Lp 10% Owner   –       –       •   2021-06-02 4 A $0.00 $0 D/D 22,766 61,845     -
   Moukheibir Catherine Director   –       •      –    2021-06-02 4 A $0.00 $0 D/D 22,766 71,760     -
   Olanoff Lawrence S Director   –       •      –    2021-06-02 4 A $0.00 $0 D/D 22,766 91,395     -
   Mccourt Thomas A President and Interim CEO   •       –      –    2021-05-24 4 AS $12.25 $21,021 D/D (1,716) 566,499 12%     
   Rickard Jason SVP, Chief Operating Officer   •       –      –    2021-05-24 4 AS $12.25 $6,321 D/D (516) 362,538 12%     
   Shetzline Michael CMO, SVP & Head of Drug Devt.   •       –      –    2021-05-24 4 AS $12.25 $25,443 D/D (2,077) 197,437 12%     
   Mchugh Julie Director   –       •      –    2021-04-20 4 A $0.00 $0 D/D 2,500 125,607     -
   Shetzline Michael CMO, SVP & Head of Drug Devt.   •       –      –    2021-03-26 4 A $0.00 $0 D/D 38,655 199,514     -
   Mccourt Thomas A President and Interim CEO   •       –      –    2021-03-26 4 A $0.00 $0 D/D 96,638 568,215     -
   Consylman Gina SVP, CFO & Treasurer   •       –      –    2021-03-26 4 A $0.00 $0 D/D 56,372 392,616     -
   Rickard Jason SVP, Chief Operating Officer   •       –      –    2021-03-26 4 A $0.00 $0 D/D 56,372 363,054     -
   Sarissa Capital Management Lp 10% Owner   –       –       •   2021-03-15 4 A $0.00 $0 D/D 1,235 39,079     -
   Moukheibir Catherine Director   –       •      –    2021-03-15 4 A $0.00 $0 D/D 1,573 48,994     -
   Dreyfus Andrew Director   –       •      –    2021-03-15 4 A $0.00 $0 D/D 1,460 109,097     -
   Sarissa Capital Management Lp Director   –       •       •   2021-03-10 4 B $10.54 $790,500 I/I 75,000 16,390,000 2.25 22%     
   Sarissa Capital Management Lp Director   –       •       •   2021-03-08 4 B $10.30 $1,545,000 I/I 150,000 16,315,000 2.25 22%     
   Sarissa Capital Management Lp Director   –       •       •   2021-03-05 4 B $10.01 $1,751,750 I/I 175,000 16,165,000 2.25 24%     
   Sarissa Capital Management Lp Director   –       •       •   2021-03-04 4 B $10.00 $2,500,000 I/I 250,000 15,990,000 2.25 25%     
   Sarissa Capital Management Lp Director   –       •       •   2021-03-03 4 B $10.02 $3,507,000 I/I 350,000 15,740,000 2.25 24%     
   Denner Alexander J Director   –       •      –    2021-03-02 4 B $9.56 $4,780,000 I/I 500,000 15,390,000 2.1 30%     
   Denner Alexander J Director   –       •      –    2021-03-01 4 B $9.60 $3,311,040 I/I 344,900 14,890,000 2.1 31%     
   Owens Edward P Director   –       •      –    2021-02-26 4 B $8.90 $26,700 D/D 3,000 218,954 2.39 33%     
   Rickard Jason SVP, Chief Operating Officer   •       –      –    2021-02-26 4 AS $9.11 $124,361 D/D (13,651) 306,682 33%     
   Denner Alexander J Director   –       •      –    2021-02-26 4 B $9.20 $4,646,920 I/I 505,100 14,545,100 2.1 33%     
   Mallon Mark Chief Executive Officer   •       •      –    2021-02-26 4 AS $9.11 $279,449 D/D (30,675) 470,605 33%     
  914 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us